Alternative lengthening of telomeres and Ki‐67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors
Journal of Neuroendocrinology · 2025
DOI: 10.1111/jne.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2025. Verfasst von Hallbera Gudmundsdottir und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Ki-67 Antigen, Neuroendocrine Tumors, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Robert D. and Patricia E Kern Center for the Science of Health Care Delivery, Department of Surgery at Mayo Clinic.
Abstract (Originalsprache)
Given the heterogeneous clinical behavior of pancreatic neuroendocrine tumors (pNETs), improved prognostic markers are needed to guide management and post‐resection surveillance. Patients who underwent resection of large (≥3 cm) sporadic well‐differentiated pNETs from 2000 to 2019 were identified. The Ki‐67 proliferation index was determined using immunohistochemistry, and alternative lengthening of telomeres (ALT) status was assessed using fluorescence in situ hybridization. Recurrence‐free and overall survival were estimated using Kaplan–Meier analysis. Multivariable Cox regression analysis evaluated factors associated with recurrence‐free survival. A total of 106 patients were identified. ALT was positive in 57 (54%) and negative in 49 (46%). Ki‐67 was ≥3% in 74 (70%) and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Medical Genome Facility, Cytogenetics Core Laboratory, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Hallbera Gudmundsdottir
Förderung
- Robert D. and Patricia E Kern Center for the Science of Health Care Delivery
- Department of Surgery at Mayo Clinic
Zitieren
APA
Gudmundsdottir, H., Graham, R. P., Greipp, P. T., Habermann, E. B., Knudson, R. A., Brandt, C. A., Starlinger, P., Thiels, C. A., Warner, S. G., Smoot, R. L., Truty, M. J., Kendrick, M. L., Nagorney, D. M., Cleary, S. P., & Halfdanarson, T. R. (2025). Alternative lengthening of telomeres and Ki‐67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70003
Vancouver
Gudmundsdottir H, Graham RP, Greipp PT, Habermann EB, Knudson RA, Brandt CA, et al. Alternative lengthening of telomeres and Ki‐67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors. Journal of Neuroendocrinology. 2025. doi:10.1111/jne.70003
BibTeX
@article{Gudmundsdottir2025,
author = {Gudmundsdottir, Hallbera and Graham, Rondell P and Greipp, Patricia T and Habermann, Elizabeth B and Knudson, Ryan A and Brandt, Carrie A and Starlinger, Patrick and Thiels, Cornelius A and Warner, Susanne G and Smoot, Rory L and Truty, Mark J and Kendrick, Michael L and Nagorney, David M and Cleary, Sean P and Halfdanarson, Thorvardur R},
title = {Alternative lengthening of telomeres and Ki‐67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors},
journal = {Journal of Neuroendocrinology},
year = {2025},
doi = {10.1111/jne.70003}
}
EUVIMED